Information for NHS Organisations and Staff

Subscribe to page updates

Topics

Medicines

Medical devices and clinical consumables

Non-clinical consumables, goods and services

Workforce

Data

Reciprocal healthcare and cost recovery

Research and clinical networks

Vaccines

Blood and transplant

 

Medicines

  • Prescribe and dispense as normal: doctors and pharmacists should explain to patients that they should continue to order their prescriptions as normal. Prescriptions covering longer durations than normally prescribed should be avoided. Prescription durations will be monitored and investigated where necessary.
  • Provide patients with information: NHS leaders and clinicians should keep patients and health professionals informed about plans for continuity of supply.
  • Don’t stockpile locally: It is not helpful or appropriate for anyone to stockpile medicines locally – organisations stockpiling risks pressure on availability of medicines. Hospital stock levels will be monitored and over-ordering of medicines will be investigated.
  • Report shortages through usual routes: Any shortages should be reported through usual routes. A national Medicines Shortage Response Group will provide clear governance, communication and decision-making to improve the management of medicine shortages.
  • Ensure your organisation is familiar with the latest information on supply disruption: This includes making sure your organisation is able to share the information in supply disruption emails, Central Alerting System alerts and other system communications with clinicians. Medicines shortages will be managed at a national level in line with usual practice.

There is also information for patients on the NHS website.

Return to top

Medical devices and clinical consumables

  • Measures are in place to help ensure that even if there are transport delays, stocks will continue to be available.
  • Do not stockpile products. Organisations should maintain business as usual stock levels.
  • Delivery times of goods may change. Ensure all staff are aware of these changes in practice and that business continuity plans are in place.

Return to top

Non-clinical consumables, goods and services

  • National and local measures are in place to help ensure that the non-clinical goods and services the NHS needs to function continue to be available.
  • If you have a concern about a consumable or service your organisation relies on, speak with your organisation’s Senior Responsible Officer.

Return to top

Workforce

  • The government and the NHS support EU staff, who make an important contribution to health and social care services across the UK. Your contribution to the NHS is vital and everything possible is being done to ensure you are able to continue your work providing world-class care with the NHS after the UK’s departure from the EU.
  • If you are an EU citizen legally resident in the UK at exit day, then your employment contract will not change and you will have no problem carrying on working as you do now. If you have not already done so, you are encouraged to apply to the EU Settlement Scheme.
  • The EU Settlement Scheme is open to all EU citizens, including NHS staff, and can allow you to gain ‘settled’ or ‘pre-settled status’.
  • Legislation has been put into place that continues to recognise EEA and Swiss qualifications. If you are registered with the General Medical Council, Nursing and Midwifery Council, General Pharmaceutical Council, General Dental Council, or Health and/or Care Professions Council, your registration will continue after the UK leaves the EU, regardless of whether a deal is agreed.
  • There will be no need for any change to existing employment contracts if the UK leaves the EU without a deal and therefore no question of EU staff needing to reapply for their own jobs because of EU Exit.
  • For any professional registration queries, please contact your relevant professional regulator.

Return to top

Data

  • NHS organisations and staff should continue to handle data in the same way they currently do (which is covered by General Data Protection Regulation).
  • Your organisation’s data protection officer should have put in place safeguards to ensure that data flows to and from the UK and the EEA will continue uninterrupted after exit day.

Return to top

Reciprocal healthcare and cost recovery

This information will apply if the UK leaves the EU without a deal.

  • Healthcare cover may change for EU citizens who visit the UK after exit day and whose country does not have a reciprocal healthcare agreement with the UK. Those visitors will be charged for accessing NHS healthcare, unless it is a service that would be free of charge for everyone, or they are exempt from charging.
  • In a scenario without a deal, amended charging regulations will come into force from exit day. Guidance on these amended regulations is on the Department of Health and Social Care website.
  • The Department of Health and Social Care, NHS England and NHS Improvement will provide updates and further information as the position on post-EU exit reciprocal arrangements develops.

Return to top

Research and clinical networks

  • The NHS and the UK government are working with organisations running clinical trials to help ensure that research continues as normal in the coming months. They have encouraged these organisations to consider their supply chains for clinical trials and ensure appropriate supplies of trial drugs and medical products are in place.
  • Continue participating in and/or recruiting patients to clinical trials and investigations. Only stop recruitment to trials where you are requested to do so by a trial sponsor, the organisation managing the trial or clinical investigation, or through formal communications from the Medicines and Healthcare Products Regulatory Agency.

Return to top

Vaccines

  • Don’t stockpile vaccines beyond business as usual levels. Over-ordering will be investigated.
  • All organisations should reassure patients that arrangements are in place to ensure that the vaccines they may need will be available after we leave the EU.

Return to top

Blood and transplant

  • Hospitals should expect NHS Blood and Transplant to behave as it does now, including arrangements for reference services.
  • Organisations should not stockpile products from NHS Blood and Transplant.
  • Continue to order/request tissue products and stem cells as normal. Hospitals should not stockpile tissues.
  • If you have any questions, direct these through your local NHS Blood and Transplant hospital customer services manager.

Return to top